American International Group’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-645
| Closed | -$29.1K | – | 410 |
|
|
2024
Q1 | $29.1K | Buy |
645
+15
| +2% | +$676 | ﹤0.01% | 2882 |
|
|
2023
Q4 | $29.7K | Sell |
630
-3
| -0.5% | -$142 | ﹤0.01% | 2917 |
|
|
2023
Q3 | $25.6K | Buy |
633
+56
| +10% | +$2.27K | ﹤0.01% | 2960 |
|
|
2023
Q2 | $61.5K | Hold |
577
| – | – | ﹤0.01% | 2828 |
|
|
2023
Q1 | $172K | Buy |
577
+12
| +2% | +$3.58K | ﹤0.01% | 2201 |
|
|
2022
Q4 | $194K | Sell |
565
-2
| -0.4% | -$688 | ﹤0.01% | 2142 |
|
|
2022
Q3 | $107K | Buy |
567
+8
| +1% | +$1.51K | ﹤0.01% | 2517 |
|
|
2022
Q2 | $118K | Buy |
559
+24
| +4% | +$5.07K | ﹤0.01% | 2495 |
|
|
2022
Q1 | $179K | Sell |
535
-38
| -7% | -$12.7K | ﹤0.01% | 2303 |
|
|
2021
Q4 | $186K | Sell |
573
-17
| -3% | -$5.52K | ﹤0.01% | 2415 |
|
|
2021
Q3 | $286K | Buy |
590
+55
| +10% | +$26.7K | ﹤0.01% | 2213 |
|
|
2021
Q2 | $249 | Buy |
535
+69
| +15% | +$32 | ﹤0.01% | 2366 |
|
|
2021
Q1 | $321 | Buy |
466
+2
| +0.4% | +$1 | ﹤0.01% | 2095 |
|
|
2020
Q4 | $343 | Buy |
464
+26
| +6% | +$19 | ﹤0.01% | 1973 |
|
|
2020
Q3 | $304K | Buy |
438
+33
| +8% | +$22.9K | ﹤0.01% | 1877 |
|
|
2020
Q2 | $343K | Buy |
405
+148
| +58% | +$125K | ﹤0.01% | 1791 |
|
|
2020
Q1 | $92K | Sell |
257
-15
| -6% | -$5.37K | ﹤0.01% | 2352 |
|
|
2019
Q4 | $63K | Buy |
272
+34
| +14% | +$7.88K | ﹤0.01% | 2819 |
|
|
2019
Q3 | $27K | Sell |
238
-2
| -0.8% | -$227 | ﹤0.01% | 2988 |
|
|
2019
Q2 | $42K | Buy |
+240
| New | +$42K | ﹤0.01% | 2982 |
|